Qiagen NV
NYSE:QGEN
Intrinsic Value
QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. [ Read More ]
The intrinsic value of one QGEN stock under the Base Case scenario is 41.48 USD. Compared to the current market price of 42.75 USD, Qiagen NV is Overvalued by 3%.
Valuation Backtest
Qiagen NV
Run backtest to discover the historical profit from buying and selling QGEN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Qiagen NV's business.
What risks and challenges
does Qiagen NV face in the near future?
Summarize the latest earnings report
of Qiagen NV.
Provide P/E
for Qiagen NV and its competitors.
Balance Sheet Decomposition
Qiagen NV
Current Assets | 2.1B |
Cash & Short-Term Investments | 1.1B |
Receivables | 396.9m |
Other Current Assets | 692.9m |
Non-Current Assets | 4B |
Long-Term Investments | 20.6m |
PP&E | 765m |
Intangibles | 3B |
Other Non-Current Assets | 179.4m |
Current Liabilities | 1.1B |
Accounts Payable | 84.2m |
Accrued Liabilities | 325.1m |
Other Current Liabilities | 670.1m |
Non-Current Liabilities | 1.2B |
Long-Term Debt | 921.8m |
Other Non-Current Liabilities | 306.3m |
Earnings Waterfall
Qiagen NV
Revenue
|
2B
USD
|
Cost of Revenue
|
-731.6m
USD
|
Gross Profit
|
1.2B
USD
|
Operating Expenses
|
-788.4m
USD
|
Operating Income
|
445.2m
USD
|
Other Expenses
|
-103.9m
USD
|
Net Income
|
341.3m
USD
|
Free Cash Flow Analysis
Qiagen NV
What is Free Cash Flow?
QGEN Profitability Score
Profitability Due Diligence
Qiagen NV's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Qiagen NV's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
QGEN Solvency Score
Solvency Due Diligence
Qiagen NV's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Score
Qiagen NV's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
QGEN Price Targets Summary
Qiagen NV
According to Wall Street analysts, the average 1-year price target for QGEN is 52.02 USD with a low forecast of 44.25 USD and a high forecast of 63 USD.
Shareholder Return
QGEN Price
Qiagen NV
Average Annual Return | 8.8% |
Standard Deviation of Annual Returns | 33.01% |
Max Drawdown | -39% |
Market Capitalization | 9.5B USD |
Shares Outstanding | 221 336 992 |
Percentage of Shares Shorted | 1.82% |
QGEN News
Last Important Events
Qiagen NV
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Qiagen NV
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company is headquartered in Venlo, Limburg and currently employs 6,028 full-time employees. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Contact
IPO
Employees
Officers
The intrinsic value of one QGEN stock under the Base Case scenario is 41.48 USD.
Compared to the current market price of 42.75 USD, Qiagen NV is Overvalued by 3%.